Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116(Pt 2):217–224. https://doi.org/10.1242/jcs.00229

Article  CAS  PubMed  Google Scholar 

Babyatsky MW, Rossiter G, Podolsky DK (1996) Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110(4):975–984. https://doi.org/10.1053/gast.1996.v110.pm8613031

Article  CAS  PubMed  Google Scholar 

Biancheri P, Giuffrida P, Docena GH, MacDonald TT, Corazza GR, Di Sabatino A (2014) The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev 25(1):45–55. https://doi.org/10.1016/j.cytogfr.2013.11.001

Article  CAS  PubMed  Google Scholar 

Coimbra A, Rimola J, Cuatrecasas M, De Hertogh G, Van Assche G, Vanslembrouck R, Glerup H, Nielsen AH, Hagemann-Madsen R, Bouhnik Y, Zappa M, Cazals-Hatem D, D’Haens G, Stoker J, Meijer S, Rogler G, Boss A, Weber A, Zhao R, Keir ME, Scherl A, de Crespigny A, Lu TT, Panés J (2022) Magnetic resonance enterography and histology in patients with fibrostenotic Crohn’s Disease: a multicenter study. Clin Transl Gastroenterol 13(7):e00505. https://doi.org/10.14309/ctg.0000000000000505

Article  PubMed  PubMed Central  Google Scholar 

Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250. https://doi.org/10.1097/00054725-200207000-00002

Article  PubMed  Google Scholar 

Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen F, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR, Group C-S, Consortium SCT (2007) Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 56(1):323–333. https://doi.org/10.1002/art.22289

Article  CAS  PubMed  Google Scholar 

Fernandez IE, Eickelberg O (2012) The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 9(3):111–116. https://doi.org/10.1513/pats.201203-023AW

Article  CAS  PubMed  Google Scholar 

Lafyatis R (2014) Transforming growth factor β–at the centre of systemic sclerosis. Nat Rev Rheumatol 10(12):706–719. https://doi.org/10.1038/nrrheum.2014.137

Article  CAS  PubMed  Google Scholar 

Martin JC, Chang C, Boschetti G, Ungaro R, Giri M, Grout JA, Gettler K, Chuang LS, Nayar S, Greenstein AJ, Dubinsky M, Walker L, Leader A, Fine JS, Whitehurst CE, Mbow ML, Kugathasan S, Denson LA, Hyams JS, Friedman JR, Desai PT, Ko HM, Laface I, Akturk G, Schadt EE, Salmon H, Gnjatic S, Rahman AH, Merad M, Cho JH, Kenigsberg E (2019) Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-tnf therapy. Cell 178(6):1493-1508.e1420. https://doi.org/10.1016/j.cell.2019.08.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKaig BC, Hughes K, Tighe PJ, Mahida YR (2002) Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 282(1):C172-182. https://doi.org/10.1152/ajpcell.00048.2001

Article  CAS  PubMed  Google Scholar 

Mittl PR, Priestle JP, Cox DA, McMaster G, Cerletti N, Grütter MG (1996) The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci 5(7):1261–1271. https://doi.org/10.1002/pro.5560050705

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, Hsu FJ, Berzofsky JA, Lawrence DP (2014) Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS ONE 9(3):e90353. https://doi.org/10.1371/journal.pone.0090353

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun T, Huang Z, Liang WC, Yin J, Lin WY, Wu J, Vernes JM, Lutman J, Caplazi P, Jeet S, Wong T, Wong M, DePianto DJ, Morshead KB, Sun KH, Modrusan Z, Vander Heiden JA, Abbas AR, Zhang H, Xu M, N’Diaye EN, Roose-Girma M, Wolters PJ, Yadav R, Sukumaran S, Ghilardi N, Corpuz R, Emson C, Meng YG, Ramalingam TR, Lupardus P, Brightbill HD, Seshasayee D, Wu Y, Arron JR (2021) TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis. Sci Transl Med. https://doi.org/10.1126/scitranslmed.abe0407

Article  PubMed  PubMed Central  Google Scholar 

Uzzan M, Martin JC, Mesin L, Livanos AE, Castro-Dopico T, Huang R, Petralia F, Magri G, Kumar S, Zhao Q, Rosenstein AK, Tokuyama M, Sharma K, Ungaro R, Kosoy R, Jha D, Fischer J, Singh H, Keir ME, Ramamoorthi N, O’Gorman WE, Cohen BL, Rahman A, Cossarini F, Seki A, Leyre L, Vaquero ST, Gurunathan S, Grasset EK, Losic B, Dubinsky M, Greenstein AJ, Gottlieb Z, Legnani P, George J, Irizar H, Stojmirovic A, Brodmerkel C, Kasarkis A, Sands BE, Furtado G, Lira SA, Tuong ZK, Ko HM, Cerutti A, Elson CO, Clatworthy MR, Merad M, Suárez-Fariñas M, Argmann C, Hackney JA, Victora GD, Randolph GJ, Kenigsberg E, Colombel JF, Mehandru S (2022) Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat Med 28(4):766–779. https://doi.org/10.1038/s41591-022-01680-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang YE (2017) Non-smad signaling pathways of the tgf-β family. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a022129

Article  PubMed  PubMed Central  Google Scholar